Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B.
Sacco M, Testa MF, Ferretti A, Basso M, Lancellotti S, Tardugno M, Di Gennaro L, Concolino P, Minucci A, Spoliti C, Branchini A, De Cristofaro R. Sacco M, et al. Among authors: de cristofaro r. J Thromb Haemost. 2024 Oct;22(10):2724-2738. doi: 10.1016/j.jtha.2024.07.008. Epub 2024 Jul 15. J Thromb Haemost. 2024. PMID: 39019441 Free article.
Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients.
Battafarano G, Lancellotti S, Sacco M, Rossi M, Terreri S, Di Gregorio J, Di Giuseppe L, D'Agostini M, Porzio O, Di Gennaro L, Tardugno M, Pelle S, Minisola S, Toniolo RM, Luciani M, Del Fattore A, De Cristofaro R. Battafarano G, et al. Among authors: de cristofaro r. Sci Rep. 2024 Oct 23;14(1):25001. doi: 10.1038/s41598-024-75747-w. Sci Rep. 2024. PMID: 39443571 Free PMC article.
Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity.
Peyvandi F, Di Michele D, Bolton-Maggs PH, Lee CA, Tripodi A, Srivastava A; Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Peyvandi F, et al. J Thromb Haemost. 2012 Sep;10(9):1938-43. doi: 10.1111/j.1538-7836.2012.04844.x. J Thromb Haemost. 2012. PMID: 22943259 Free article. No abstract available.
Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.
Fianchi L, Bonanni M, Borchiellini A, Valeri F, Giuffrida G, Grasso S, Fozza C, Ponta M, Tiscia GL, Grandone E, Vianelli N, Dedola A, Pirozzi T, Sacco M, Lancellotti S, De Cristofaro R. Fianchi L, et al. Among authors: de cristofaro r. J Clin Med. 2024 Oct 31;13(21):6561. doi: 10.3390/jcm13216561. J Clin Med. 2024. PMID: 39518700 Free PMC article.
The in-hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta-analysis.
Di Pietro G, Improta R, Severino P, D'Amato A, Birtolo LI, De Filippo O, Lattanzio A, De Cristofaro R, Galardo G, D'Ascenzo F, Badagliacca R, Sardella G, Volterrani M, Fedele F, Vizza CD, Mancone M. Di Pietro G, et al. Among authors: de cristofaro r. ESC Heart Fail. 2024 Oct 29. doi: 10.1002/ehf2.15082. Online ahead of print. ESC Heart Fail. 2024. PMID: 39473218 Free article. Review.
Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy.
Federici AB, Santoro RC, Santoro C, Pieri L, Santi RM, Barillari G, Borchiellini A, Tosetto A, Zanon E, De Cristofaro R, Mairal E, Mir R. Federici AB, et al. Among authors: de cristofaro r. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241264541. doi: 10.1177/10760296241264541. Epub 2024 Jul 21. Clin Appl Thromb Hemost. 2024. PMID: 39033425 Free PMC article.
254 results